Skip to main content
SNO 28th Annual Meeting Main banner
Final Program


Program
Icon Legend
Presentation Icons
CME
CME
Non-CME
Non-CME
ISS CME
ISS CME
Named Award Winner
Named Award Winner
Award Winner
Award Winner
Poster Award Winner
Poster Award Winner
Back
Video

Session: Concurrent Session: Biostatistics for Clinical Trial Design

GBM AGILE Platform Trial for Newly Diagnosed and Recurrent GBM: Results of First Experimental Arm, Regorafenib

Friday, November 17, 2023
5:00 PM – 5:10 PM PT
Location: Ballroom A
CME

    Concurrent Session Speaker(s)

  • Patrick Y. Wen

    Dana-Farber Cancer Institute
    Boston, Massachusetts, United States